The Study of efficacy and tolerability of adjunctive therapy with Zonisamide in adulthood intractable epilepsy
Phase 2
- Conditions
- Epilepsy.Episodic and paroxysmal disorders
- Registration Number
- IRCT138811153278N1
- Lead Sponsor
- Isfahan University Of Medical Sciences and Health Services
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 56
Inclusion Criteria
1) Sizure Frequency =4per month inspite of treatment with 2 AED( Intractable Seizure)
2) Age above 17
3) Any types of Seizure Disorders
Exclusion Critera:
1) Having progressive encephalopathy or any structral disorders of central nervous system now or before takeing part into this study
2) Having any diseases such as eyes, heart, blood, kidney, liver now or before taking part into this study
3) sulfunamide sensitivity
4) Married women in pregnancy ages
5) Using Acetazolamide as an AED
6) Not having any cooperation in using drug
7) Any severe side effects of drug
8) Not having consensus abot continuation of the study
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Seizure frequency. Timepoint: 1 week, 2 week, 3 week, 1 month, 2 month, 3 month. Method of measurement: assesment of seizure frequency with asking from patients and filling questionnaire.;Side effects. Timepoint: 1st week, 2nd week, 3rd week, 4th week, 2nd month, 3rd month. Method of measurement: Assesment of side effect by asking patients and filling a questionnaire.
- Secondary Outcome Measures
Name Time Method